Stay updated on Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.

Latest updates to the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now renders a 403 Forbidden error page, replacing the study content and navigation with an access-denied message. This blocks viewing the trial details and indicates an access/server issue rather than a change to the study data.SummaryDifference21%

- Check40 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a new deployment of the page. This change affects only the page's version metadata and does not modify study content or visible functionality.SummaryDifference0.0%

- Check61 days agoChange DetectedThe footer now shows Revision: v3.6.5, replacing the previous v3.6.4. This is a minor site version update and does not change trial details or functionality.SummaryDifference0.0%

- Check76 days agoChange DetectedThe Nat Commun reference on spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer was updated from an online-ahead-of-print entry to the final published version with DOI 10.1038/s41467-026-72204-2. The page revision tag was updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page's revision label now shows Revision: v3.6.3 instead of v3.6.2.SummaryDifference0.0%

- Check104 days agoChange DetectedFooter revision tag updated from v3.6.0 to v3.6.2, representing a minor internal update to the page; this does not alter the displayed study data or page functionality.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.